Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
Clinical trial NCT00529698 · COMPLETED
Trial details
- NCT number
- NCT00529698
- Sponsor
- Istituto Superiore di Sanità
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.